Study on clinical features and complications with systemic lupus erythematosus (SLE) activity in Chinese Han population

被引:0
作者
Lian Hong Li
Hai Feng Pan
Wen Xian Li
Xiang Pei Li
Jian Hua Xu
Dong Qing Ye
机构
[1] Anhui Medical University,Department of Epidemiology and Biostatistics, School of Public Health
[2] Anhui Provincial Hospital,Department of Rheumatology
[3] Anhui Medical University,Department of Rheumatology, First Affiliated Hospital
来源
Clinical Rheumatology | 2009年 / 28卷
关键词
Clinical profile; Disease activity; SLEDAI; Systemic lupus erythematosus;
D O I
暂无
中图分类号
学科分类号
摘要
Systemic lupus erythematosus (SLE) is a complex autoimmune disease affecting multiple organs/systems with variable activities. We performed a retrospective study to investigate the relationship of clinical characteristics and complications with SLE activity in Chinese Han population. A cohort of 1,490 SLE inpatients was evaluated for disease activity using the systemic lupus erythematosus disease activity index (SLEDAI). Chi-square test or Fisher’s exact test was used to compare differences of clinical and laboratory features between active and inactive SLE patients. Logistic regression was chosen to explore the pattern of risk factors for disease activity. We found that neuropsychiatric involvement, nephritis, arthralgia, anti-dsDNA, serositis, hypocomplementemia, oral ulcerations, erythrocyte sedimentation rate, low C3, hematological abnormalities, and systolic pressure (1.010 < odds ratio < 10.568, 1.002 < 95% confidence interval < 31.599, 0.000 < P < 0.026) were major factors associated with disease activity, but not headaches, anti-ribonucleoprotein or anti-Sm, C-reactive protein, and anemia (P > 0.05, respectively). The involvements of urinary system, respiratory system, and central nervous system were significantly more frequent in active SLE than inactive SLE (0.000 < P < 0.014), except for alimentary system (P = 0.399). Our study has comprehensively evaluated the relationship of clinical characteristics and organs/systems involvement of SLE with SLEDAI in Chinese Han population and presented a compendium of factors affecting SLE, which should be useful for better evaluating disease activity and predicting organs/systems damage in SLE for clinical assessments and managements.
引用
收藏
页码:1301 / 1307
页数:6
相关论文
共 171 条
[1]  
Bombardier C(1992)Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE Arthritis Rheum 35 630-640
[2]  
Gladman DD(2004)The systemic lupus activity measure-revised, the Mexican Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), and a modified SLEDAI-2K are adequate instruments to measure disease activity in systemic lupus erythematosus J Rheumatol 31 1934-1940
[3]  
Urowitz MB(2001)Enhanced serum prolactin (PRL) in patients with systemic lupus erythematosus: PRL levels are related to the disease activity Lupus 10 554-561
[4]  
Caron D(2006)Anti-dsDNA and anti-Sm antibodies do not predict damage in systemic lupus erythematosus Lupus 15 285-291
[5]  
Chang CH(2004)Hypocomplementemia in systemic lupus erythematosus and primary antiphospholipid syndrome: prevalence and clinical significance in 667 patients Lupus 13 777-783
[6]  
Uribe AG(2004)Predictive value of autoantibodies for activity of systemic lupus erythematosus Lupus 13 290-297
[7]  
Vila LM(2003)Association of damage with autoantibody profile, age, race, sex and disease duration in systemic lupus erythematosus Rheumatology (Oxford) 42 276-279
[8]  
McGwin G(2007)Systemic lupus erythematosus in a multiethnic US cohort LUMINA LI: anaemia as a predictor of disease activity and damage accrual Rheumatology (Oxford) 46 1471-1476
[9]  
Sanchez ML(2005)Systemic lupus erythematosus in a multiethnic cohort (LUMINA): XXIX. Elevation of erythrocyte sedimentation rate is associated with disease activity and damage accrual J Rheumatol 32 2150-2155
[10]  
Reveille JD(2006)Systemic lupus erythematosus in a multiethnic US cohort, XXXVII: association of lymphopenia with clinical manifestations, serologic abnormalities, disease activity, and damage accrual Arthritis Rheum 55 799-806